Office of Infectious Diseases (OID) - Division of Antivirals (DAV)
The Division of Antivirals (DAV) oversees the development, review, and regulation of applications for products that are being developed to prevent or treat infections caused by viruses (e.g., influenza, hepatitis, respiratory syncytial virus (RSV), human immunodeficiency virus 1 [HIV-1], and adenovirus).
Resources:
- Information for Pre-IND Submissions
- Expanded Access Programs
- Guidances: For DAV specific and/or relevant guidance documents (draft or final)
- Advisory Committee Meetings: Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee)
- Public Meetings (Upcoming and Past)